Closed Loop Medicine, a Cambridge, and London, UK-based health tech startup, raised £2.1M in Pre-Series A funding.
Backers included Longwall Venture Partners, IQ Capital and Martlet, the investment arm of the Marshall of Cambridge group, as well as Cambridge Angel investors, including well-known serial entrepreneur Sherry Coutu CBE.
Founded in 2017 by Dr Hakim Yadi OBE, CEO, Dr Paul Goldsmith, Dr David Cox and Dr Felicity Sartain, Closed Loop Medicine is a therapeutics company that combines proven drug treatments with digital therapeutics. Digital therapeutics deliver evidence-based therapeutic interventions to patients that are driven by high quality software programs to prevent, manage, or treat a medical disorder or disease.
The company’s approach uses data and insights about how a patient is responding to treatment to tailor drug and non-drug therapy.
The company intends to use the funds for the development of a drug + digital approach to treat and manage major health conditions our society faces, starting with sleep disturbance and hypertension. It intends to develop fully regulated, evidence-based Drug + Digital solutions for the NHS and international healthcare providers.
This recent funding round has also enabled the company to take offices in London, invest in technical product development, start clinical development and clinical trials as well as invest further in drug development. The funding has also been used to recruit the current management team, as well as support building out the CLM tech team.